Correlation Between Enlivex Therapeutics and Universal Security

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Universal Security at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Universal Security into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and Universal Security Instruments, you can compare the effects of market volatilities on Enlivex Therapeutics and Universal Security and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Universal Security. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Universal Security.

Diversification Opportunities for Enlivex Therapeutics and Universal Security

-0.82

Correlation Coefficient

Enlivex Therapeutics  Universal Security

Pay attention - limited upside

The 3 months correlation between Enlivex and Universal is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Universal Security Instruments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universal Security and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Universal Security. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universal Security has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Universal Security go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Universal Security

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Universal Security. In addition to that, Enlivex Therapeutics is 1.38 times more volatile than Universal Security Instruments. It trades about -0.02 of its total potential returns per unit of risk. Universal Security Instruments is currently generating about 0.05 per unit of volatility. If you would invest  162.00  in Universal Security Instruments on October 9, 2024 and sell it today you would earn a total of  72.00  from holding Universal Security Instruments or generate 44.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Enlivex Therapeutics  vs.  Universal Security Instruments

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Universal Security

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Universal Security Instruments are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Universal Security unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Enlivex Therapeutics and Universal Security

The main advantage of trading using opposite Enlivex Therapeutics and Universal Security positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Universal Security can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Security will offset losses from the drop in Universal Security's long position.

The idea behind Enlivex Therapeutics and Universal Security Instruments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.